Suppr超能文献

实验室安全:在没有生物安全柜的情况下处理伯克霍尔德氏菌分离株。

Laboratory Safety: Handling Burkholderia pseudomallei Isolates without a Biosafety Cabinet.

机构信息

University of Queensland Centre for Clinical Research, Royal Brisbane and Woman's Hospital, Herston, Queensland, Australia.

Department of Infectious Diseases, Mater Hospital Brisbane, South Brisbane, Queensland, Australia.

出版信息

J Clin Microbiol. 2021 Jun 18;59(7):e0042421. doi: 10.1128/JCM.00424-21.

Abstract

Burkholderia pseudomallei is a tier 1 select agent that is associated with laboratory-acquired melioidosis, with international guidelines recommending isolate handling within a class II biosafety cabinet (BSC) in a biosafety level 3 (BSL3) facility. In low-resource settings, this may not be practical; therefore, we aimed to assess the risk of laboratory-acquired melioidosis during routine work. Prior exposure to the organism was determined with a questionnaire and concomitant serology. Of 30 laboratory scientists handling B. pseudomallei on 1,267 occasions outside a biosafety cabinet, no infections were documented and all participants remained seronegative. Additionally, we performed controlled environmental air sampling during 78 laboratory handling events, including plate opening, oxidase testing, and McFarland suspension creation. None of the experiments demonstrated aerosolization of the organism. This study suggests the risk of laboratory-acquired melioidosis is low. However, individual laboratories will need to undertake a risk assessment, including melioidosis endemicity, availability of resources for containment, the nature of routine handling to be undertaken, and the presence of predisposing risk factors for infection in the staff concerned. Additionally, laboratories should take region-specific guidelines into consideration. Further research is required to better inform on the overall risk of infection in the microbiology laboratory.

摘要

类鼻疽伯克霍尔德菌是一种一级选择剂,与实验室获得性类鼻疽病有关,国际指南建议在三级生物安全设施(BSL3)的二级生物安全柜(BSC)中进行分离物处理。在资源匮乏的环境中,这可能不切实际;因此,我们旨在评估常规工作中实验室获得性类鼻疽病的风险。通过问卷调查和同时进行的血清学检查来确定先前是否接触过该生物体。在没有生物安全柜的情况下,有 30 名实验室科学家对 1267 次类鼻疽伯克霍尔德菌进行了处理,没有记录到感染,并且所有参与者的血清学均为阴性。此外,我们在 78 次实验室处理事件(包括平板开盖、氧化酶检测和麦氏比浊管悬液制备)期间进行了受控环境空气采样。没有一项实验显示该生物体发生了气溶胶化。本研究表明,实验室获得性类鼻疽病的风险较低。然而,各个实验室需要进行风险评估,包括类鼻疽病的流行程度、遏制资源的可用性、将要进行的常规处理的性质以及有关工作人员感染的潜在危险因素的存在。此外,实验室应考虑特定区域的指南。需要进一步的研究来更好地了解微生物学实验室中感染的总体风险。

相似文献

6
Melioidosis and safety in the clinical laboratory.类鼻疽与临床实验室安全
J Hosp Infect. 1992 Aug;21(4):301-6. doi: 10.1016/0195-6701(92)90140-h.

引用本文的文献

7
Burkholderia pseudomallei and melioidosis.伯克霍尔德氏菌和类鼻疽。
Nat Rev Microbiol. 2024 Mar;22(3):155-169. doi: 10.1038/s41579-023-00972-5. Epub 2023 Oct 4.

本文引用的文献

2
Human Melioidosis.类鼻疽病。
Clin Microbiol Rev. 2020 Mar 11;33(2). doi: 10.1128/CMR.00006-19. Print 2020 Mar 18.
6
Size distribution and buoyant density of Burkholderia pseudomallei.伯克霍尔德氏菌的大小分布和浮密度。
Arch Microbiol. 2011 Jan;193(1):69-75. doi: 10.1007/s00203-010-0649-6. Epub 2010 Nov 16.
10
Route of infection in melioidosis.类鼻疽的感染途径。
Emerg Infect Dis. 2005 Apr;11(4):638-9. doi: 10.3201/eid1104.041051.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验